One cell-one immunoglobulin. Origin of limited heterogeneity of myeloma proteins
- PMID: 5414099
- PMCID: PMC1185352
- DOI: 10.1042/bj1160241
One cell-one immunoglobulin. Origin of limited heterogeneity of myeloma proteins
Abstract
Plasma-cell tumour 5563 forms a single molecular species of immunoglobulin IgG(2)a, i.e. one variant of heavy chain and one variant of light chain. The molecules formed are labile and undergo alterations in charge properties, which rapidly lead to heterogeneity of the myeloma protein after synthesis. The single immunoglobulin species originally formed is found only after the shortest time-intervals tested, i.e. 10min incubation. Two types of changes in charge properties take place: (1) The originally formed protein (component o) is converted via an intermediate o' into the most basic form of 5563 myeloma protein found in serum (component a). Charge differences between these components are suppressed at pH8.9, but can be studied by chromatography at pH6.5 or by analysis of isoelectric points by isoelectric focusing in polyacrylamide gel. The conversion of components o and o' into component a apparently commences soon after assembly of the molecules and proceeds to completion extracellularly. (2) The second type of charge difference that distinguishes components a, b, c and d is exhibited over the pH range 6.0-8.9, but not at acid pH, and has been studied by electrophoresis at pH8.9, by chromatography and by isoelectric focusing. Conversion of component a into components b, c, d and e is only partial so that all five components can be found at decreasing concentrations in serum. Both types of charge alteration can be effected in vitro in the presence of serum, with optimum pH8.0. None of the charge differences could be attributed to the secretion process, since a component with the same isoelectric point as component o was found in secreted myeloma protein (1h). We have found no evidence to support the idea that the first type of change from component o to component a is due to ring formation of N-terminal [(14)C]glutamine into pyrrolid-2-one-5-carboxylic acid; however, our findings do not exclude this process happening very rapidly to a precursor of component o, possibly the polypeptide chain during or immediately after synthesis. In studying this point we noted that not only the heavy chains but also the kappa-type light chain of mouse 5563 myeloma protein have a blocked N-terminus.
Similar articles
-
Interchain disulphide-bond formation in the assembly of immunoglobulin G. Heavy-chain dimer as an intermediate.Biochem J. 1968 Oct;109(4):637-43. doi: 10.1042/bj1090637. Biochem J. 1968. PMID: 5683511 Free PMC article.
-
A protein related to immunoglobulin light chain detected in mouse myeloma cells.Biochem Biophys Res Commun. 1973 Mar 5;51(1):88-93. doi: 10.1016/0006-291x(73)90511-1. Biochem Biophys Res Commun. 1973. PMID: 4699568 No abstract available.
-
The formation of pyrrolid-2-one-5-carboxylic acid at the N-terminus of immunoglobulin G heavy chain.Biochem J. 1972 Aug;128(5):1221-7. doi: 10.1042/bj1281221. Biochem J. 1972. PMID: 4674626 Free PMC article.
-
The homogeneous-gamma-G-immunoglobulin produced by mouse plasmacytoma 5563 and its subsequent heterogeneity in serum.Biochem J. 1967 Feb;102(2):548-53. doi: 10.1042/bj1020548. Biochem J. 1967. PMID: 4166041 Free PMC article.
-
Molecular analysis of spontaneous somatic mutants.Nature. 1977 Jan 27;265(5592):299-304. doi: 10.1038/265299a0. Nature. 1977. PMID: 401950 Review.
Cited by
-
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants.Antibodies (Basel). 2022 Nov 20;11(4):73. doi: 10.3390/antib11040073. Antibodies (Basel). 2022. PMID: 36412839 Free PMC article. Review.
-
Discovery of a chemical modification by citric acid in a recombinant monoclonal antibody.Anal Chem. 2014 Sep 16;86(18):8932-6. doi: 10.1021/ac502179m. Epub 2014 Aug 27. Anal Chem. 2014. PMID: 25136741 Free PMC article.
-
Arginine modifications by methylglyoxal: discovery in a recombinant monoclonal antibody and contribution to acidic species.Anal Chem. 2013 Dec 3;85(23):11401-9. doi: 10.1021/ac402384y. Epub 2013 Nov 18. Anal Chem. 2013. PMID: 24168114 Free PMC article.
-
Characterization of monoclonal antibodies against altered (T103I) amidase from Pseudomonas aeruginosa.Mol Biotechnol. 2005 Jul;30(3):207-19. doi: 10.1385/MB:30:3:207. Mol Biotechnol. 2005. PMID: 15988046
-
Purification and characterization of monoclonal antibodies against the free alpha-subunit of human chorionic gonadotrophin.Mol Biotechnol. 2001 Feb;17(2):119-28. doi: 10.1385/MB:17:2:119. Mol Biotechnol. 2001. PMID: 11395860
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources